Patent Application for Dichrostachys glomerata to Reduce Anxiety and Cravings

ChangeBridge: Patent Apps - Therapeutics (A61P)

Published September 25th, 2024

Detected March 27th, 2026

Summary

The USPTO has published a new patent application (US20260083792A1) for methods and compositions using Dichrostachys glomerata to reduce anxiety, stress, food cravings, and improve mood and overall health. The application was filed on September 25, 2024, by inventor Shil Kothari.

View original document View source feed page

What changed

This document is a publication of a patent application filed with the USPTO, detailing methods and compositions utilizing Dichrostachys glomerata for various health benefits, including reducing anxiety, stress, and food cravings, and improving mood and energy. The application, filed on September 25, 2024, by Shil Kothari, specifies oral dosage forms such as pills, capsules, liquids, lozenges, or tablets.

As this is a patent application, it does not impose immediate regulatory requirements or compliance deadlines on regulated entities. However, companies in the pharmaceutical and health supplement sectors should monitor the progress of this application and similar innovations, as granted patents can lead to exclusive rights and influence market competition and product development in the future.

Source document (simplified)

← USPTO Patent Applications

METHODS AND COMPOSITIONS USING DICHROSTACHYS GLOMERATA TO REDUCE ANXIETY, FOOD CRAVINGS AND STRESS AND IMPROVE MOOD, PHYSICAL HEALTH, MENTAL HEALTH, ENERGY AND HAPPINESS IN A MAMMAL

Application US20260083792A1 Kind: A1 Mar 26, 2026

Inventors

Shil Kothari

Abstract

Methods and related compositions using Dichrostachys glomerata to provide a variety of health and wellness benefits in a mammal. More specifically, methods and compositions using Dichrostachys glomerata to reduce anxiety, food cravings, stress and improve mood, physical health, mental health, energy and happiness and improve other quality of life factors in one or more mammals, are provided. In one embodiment, a composition for reducing food cravings in a mammal is provided, wherein the composition comprises an effective amount of Dichrostachys glomerata fruit pods provided as an oral dosage unit in the form of a pill, capsule, liquid, lozenge or tablet.